Atomoxetine
- Product NDC
- 42291-066
- 11-digit product format
- 422910066
- Labeler code
- 42291
- Product ID
- 42291-066_485b5018-57ec-90d7-e063-6294a90ae5e2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atomoxetine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA079022
- Marketing category
- ANDA
- Marketing start
- 2022-04-12
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079022-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079022-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079022-001 | AB |
| A079022-002 | AB |
| A079022-003 | AB |
| A079022-004 | AB |
| A079022-005 | AB |
| A079022-006 | AB |
| A079022-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079022-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079022-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079022-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079022-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atomoxetine | ATOMOXETINE | AvKARE | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 42291-066 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | ddec2943-483d-403a-838c-cbdb6eefe0a1 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 96855061-440f-4c99-a152-cf8da8e2b1b3 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | aa109260-6d4c-429c-9957-19cbe0e34485 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 402711d7-bd44-4f2a-ad2b-4756cdc68645 | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 |
| Atomoxetine | ATOMOXETINE | Teva Pharmaceuticals USA, Inc. | 4953df7b-ccdb-452c-8699-5fd7259609b4 | 2023-04-21 | Boxed warning, Warnings, Adverse reactions | 079022 ANDA079022 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atomoxetine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOMOXETINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57WVB6I2W0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| dc7ba02c-bdbb-5136-e053-2995a90ac545 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d16f546-db6a-1939-50fc-d06382424c97 | Product name | 4 | 20210903 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42291-066-30 | Atomoxetine | 30 in 1 BOTTLE | CAPSULE | 30 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-066-30 | EA - Each | 42291-066 | 84af4692-a917-4c86-bccd-ad1a3cee3f9f | 1 | 2022-05-04 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349591 | atomoxetine HCl 10 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608139 | atomoxetine HCl 100 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349592 | atomoxetine HCl 18 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349593 | atomoxetine HCl 25 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349594 | atomoxetine HCl 40 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349595 | atomoxetine HCl 60 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608143 | atomoxetine HCl 80 MG Oral Capsule | PSN | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349591 | atomoxetine 10 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608139 | atomoxetine 100 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349592 | atomoxetine 18 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349593 | atomoxetine 25 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349594 | atomoxetine 40 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349595 | atomoxetine 60 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608143 | atomoxetine 80 MG Oral Capsule | SCD | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349591 | atomoxetine 10 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608139 | atomoxetine 100 MG (as atomoxetine HCl) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349592 | atomoxetine 18 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349593 | atomoxetine 25 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349594 | atomoxetine 40 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 349595 | atomoxetine 60 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
| 608143 | atomoxetine 80 MG (as atomoxetine hydrochloride) Oral Capsule | SY | dc7ba02c-bdbb-5136-e053-2995a90ac545 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 42291-066-30 | 42291006630 | 30 CAPSULE in 1 BOTTLE (42291-066-30) | 30 capsule | 2022-04-12 | 0000-00-00 | No | No | Current |